Seroprevalence of Infection by Borrelia Species Responsible for Lyme Disease in the French Alps: Analysis of 27,360 Serology Tests, 2015–2020
Authors:
- 8 April 2024
- journal article
- research article
- Published by SAGE Publications in Vector-Borne and Zoonotic Diseases
- Vol. 24 (4) , 196-200
Abstract
Objectives: Lyme borreliosis incidence is increasing in several areas; moreover, it has recently gained the public's attention. Apart from erythema migrans, Lyme disease diagnosis relies (among others) on serology test; however, the prevalence of positive enzyme-linked immunosorbent assay (ELISA) and western blot (WB) assay has been poorly studied in the general population. We aimed to approach the seroprevalence of infection by Borrelia species responsible for Lyme disease in the French Isere department using city laboratories data. Patients and Methods: We retrieved all serological tests for Borrelia species responsible for Lyme disease performed in the two main networks of city laboratories between 2015 and 2020. All patients with both ELISA and WB IgG were considered seropositive. Results: We analyzed 27,360 tests (ELISA/ELISA+WB). Mean age was 50.9 ± 20.3 years (ranges: 0–101), with 57.1% females. Overall, 11.7% had IgG detected by ELISA, and 4.7% had IgG detected by both ELISA and WB assay. Seropositive status was more frequent in males (7.0% vs. 2.9%, p < 0.001). Seropositivity rate increased with age after a first peak in childhood; men aged 61–70 years had the highest seropositivity rate (10.3%). In addition, seropositivity rate was higher in persons from a rural area. In multivariate analysis, older age, male gender and living in a rural area were independently associated with seropositivity. Seropositivity rate was stable on the 2017–2020 period. Conclusion: The seroprevalence of infection by Borrelia species responsible for Lyme disease is high in Isere; this probably reduces the predictive positive value for Lyme disease of ELISA and WB IgG, suggesting that this serological test should not be performed for nonspecific symptoms.Keywords
This publication has 34 references indexed in Scilit:
- Emergence of Lyme borreliosis in the province of Verona, Northern Italy: Five-years of sentinel surveillanceTicks and Tick-borne Diseases, 2021
- Genesis and dissemination of a controversial disease: Chronic LymeInfectious Diseases Now, 2021
- Cheminement diagnostique et vécu des patients se pensant atteints de « maladie de Lyme chronique »La Revue de Médecine Interne, 2018
- Incidence of notified Lyme borreliosis in Germany, 2013–2017Scientific Reports, 2018
- Population-based Borrelia burgdorferi sensu lato seroprevalence and associated risk factors in FinlandTicks and Tick-borne Diseases, 2018
- Human seroprevalence against Borrelia burgdorferi sensu lato in two comparable regions of the eastern Alps is not correlated to vector infection ratesTicks and Tick-borne Diseases, 2015
- Borrelia burgdorferi sensu lato serology in the Netherlands: guidelines versus daily practiceEuropean Journal of Clinical Microbiology & Infectious Diseases, 2014
- Longterm survey (7 years) in a population at risk for Lyme borreliosis: What happens to the seropositive individuals?European Journal of Epidemiology, 1998
- Tick Bites and Lyme Disease in an Endemic SettingJAMA, 1998
- Prevalence of antibodies to Borrelia burgdorferi in forestry workers of Ile de France, FranceEuropean Journal of Epidemiology, 1997